Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +0.59% | +4.91% | -68.42% |
14/05 | Transcript : GeoVax Labs, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
28/03 | GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.42% | 39.24L | |
+25.80% | 4.92TCr | |
+0.98% | 4.21TCr | |
+49.67% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.57% | 2.61TCr | |
-22.16% | 1.87TCr | |
+8.51% | 1.33TCr | |
+32.17% | 1.23TCr | |
+0.43% | 1.2TCr |
- Stock Market
- Equities
- GOVX Stock
- News GeoVax Labs, Inc.
- GeoVax Labs : Maxim Starts Geovax Labs at Buy with $8 Price Target